参考文献/References:
[1] Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation:epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res,2017,120(9):F1501-F1517.
[2] Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy,atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences[J].J Am Coll Cardiol,2015,65(20):F2239-F2251.
[3] Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol,2015,12(4):F230-F243.
[4] Andrade J, Khairy P, Dobrev D, et al.The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features,epidemiology, and mechanisms[J].Circ Res,2014,114(9):F1453-F1468.
[5]da Silva RM. Influence of inflammation and atherosclerosis in atrial fibrillation[J]. Curr Atheroscler Rep,2017,19(1):F2.
[6] Karam BS, Chavez-Moreno A, Koh W, et al. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes[J]. Cardiovasc Diabetol,2017,16(1):F120-F130.
[7] Zhu W, Yuan P, Shen Y, et al. Association of smoking with the risk of incident atrial fibrillation:a meta-analysis of prospective studies[J]. Int J Cardiol, 2016 ,218:F259-F266.
[8]Lavie CJ,Pandey A,Lau DH,et al. Obesity and atrial fibrillation prevalence, pathogenesis,and prognosis:effects of weight loss and exercise[J]. J Am Coll Cardiol,2017,70(16):F2022-F2035.
[9]Al-Falahi Z,Williamson J,Dimitri H. Atrial fibrillation and sleep apnoea:guilt by association[J]? Heart Lung Circ,2017,26(9):F902-F910.
[10]Goudis CA,Ketikoglou DG.Obstructive sleep and atrial fibrillation:pathophysiological mechanisms and therapeutic implications[J]. Int J Cardiol,2017,66(5):F361-F369.
[11]Shao Q,Liu T,Korantzopoulos P,et al. Association between air pollution and development of atrial fibrillation:a metaanalysis of observational studies[J]. Heart Lung,2016,45(6):F557-F562.
[12]Korantzopoulos P,Kokkoris S,Liu T,et al. Atrial fibrillation in end-stage renal disease[J]. Pacing Clin Electrophysiol,2007,30(11):F1391-F1397.
[13]Linz D,Hohl M,Vollmar J,et al.Atrial fibrillation and gastroesophageal reflux disease:the cardiogastric interaction[J]. Europace,2017,19(1):F16-F20.
[14]Baek YS,Kim TH,Uhm JS,et al. Prevalence and the clinical outcome of atrial fibrillation in patients with autoimmune rheumatic disease[J].Int J Cardiol,2016,9(214):F4-F9.
[15]Lazzerini PE,Capecchi PL,Laghi-Pasini F. Systemic inflammation and arrhythmic risk:lessons from rheumatoid arthritis[J]. Eur Heart J,2017,38(22):F1717-F1727.
[16]Wu N,Xu B,Xiang Y,et al.Association of inflammatory factors with occurrence and recurrence of atrial fibrillation:a meta-analysis[J].Int J Cardiol,2013,169(1):F62-F72.
[17] Suzuki A,Fukuzawa K,Yamashita T,et al. Circulating intermediate CD14 + +CD16 + monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium [J]. Europace,2017,19(1):F40-F47.
[18]Chen P,Chen J,Xie X,et al. Eosinophils in patients with lone atrial fibrillation[J]. Pacing Clin Electrophysiol,2017,40(8):F955-F958.
[19]Korantzopoulos P,Kyrlas K,Liu T,et al. Red blood cell distribution width and atrial fibrillation in patients with sick sinus syndrome[J]. J Cardiol,2016,67(185):F19-F21.
[20]Li SB,Yang F,Jing L,et al. Myeloperoxidase and risk of recurrence of atrial fibrillation after catheter ablation[J]. J Investig Med,2013,61(4):F722-F727.
[21]Fashanu OE,Norby FL,Aguilar D,et al. Galectin-3 and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities(ARIC) study[J]. Am Heart J,2017,192:F19-F25.
[22] Weymann A, Sabashnikov A, Ali-Hasan-Al-Saegh S, et al. Predictive role of coagulation, fibrinolytic, and endothelial markers in patients with atrial fibrillation, stroke, and thromboembolism: a meta-analysis, meta-regression, and systematic review [J]. Med Sci Monit Basic Res,2017,5(23):F97-F140.
[23]Ishii Y,Schuessler RB,Gaynor SL,et al. Postoperative atrial fibrillation: the role of the inflammatory response[J]. J Thorac Cardiovasc Surg,2017,153(6): F1357-F1365.
[24]Lennerz C,Barman M,Tantawy M,et al. Colchicine for primary prevention of atrial fibrillation after open-heart surgery:systematic review and meta-analysis[J]. Int J Cardiol,2017,15(249):F127-F137.
[25]Pinho-Gomes AC,Reilly S,Brandes RP,et al. Targeting inflammation and oxidative stress in atrial fibrillation:role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins[J]. Antioxid Redox Signal,2014,20(8):F1268-F1285.
[26]An J,Shi F,Liu S,et al. Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery:a meta-analysis[J]. Interact Cardiovasc Thorac Surg,2017,25(6):F958-F965.
[27]Liu T,Zhao H,Li J,et al. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits[J].Cardiovasc Ther,2014,126(2):F160-F170.
[28]Liu T, Korantzopoulos P,Shao Q,et al. Mineralocorticoid receptor antagonists and atrial fibrillation:a meta-analysis[J]. Europace,2016,167(6):F3058-F3060.
[29] Neefs J,van den Berg NW,Limpens J,et al. Aldosterone pathway blockade to prevent atrial fibrillation:a systematic review and metaanalysis[J]. Int J Cardiol,2017;231:F155-F161.
[30]Lau DH, Nattel S, Kalman JM,et al. Modifiable risk factors and atrial fibrillation [J]. Circulation,2017,136(6):F583-F596.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴亦融 徐健.心房颤动患者心房传导速度研究进展[J].心血管病学进展,2019,(9):1212.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.007]
WU Yirong,XU Jian.Atrial Conduction Velocity in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(5):1212.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.007]
[12]夏熠 刘飞 夏云龙.糖尿病合并心房颤动的相关研究进展[J].心血管病学进展,2020,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]
XIA YiLIU FeiXIA Yunlong.Research Progress in Diabetes Mellitus Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(5):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]
[13]陈稳 叶强.自噬与心房颤动关系的研究进展[J].心血管病学进展,2022,(3):218.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
CHEN Wen,YE Qiang.The Relationship Between Autophagy and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(5):218.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[14]乔宝 魏述建.心房衰竭的临床研究进展[J].心血管病学进展,2024,(1):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
QIAO Bao,WEI Shujian.Progress of Clinical Research on Atrial Failure[J].Advances in Cardiovascular Diseases,2024,(5):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
[15]麦麦提阿卜杜拉·麦麦提敏张玲 瓦沙 曹桂秋 曹佳如 汤宝鹏.48小时快速起搏对老龄犬心房病理性重构的影响[J].心血管病学进展,2024,(2):181.[doi:10.16806/j.cnki.issn.1004-3934.202.02.017]
Maimaitimin·Maimaitiabudula ZHANG Ling WA Sha CAO Guiqiu CAO Jiaru TANG Baopeng.The Effect Mechanism of 48 hour Rapid Pacing on Atrial Pathological Remodeling in Elder Canine[J].Advances in Cardiovascular Diseases,2024,(5):181.[doi:10.16806/j.cnki.issn.1004-3934.202.02.017]
[16]张晓婷 郭衍楷 汤宝鹏.心房颤动与白介素家族的研究进展[J].心血管病学进展,2024,(4):340.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.012]
ZHANG Xiaoting,GUO Yankai,TANG Baopeng.Interleukin Family and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(5):340.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.012]